Get the Stockscreener App
5.57
0.54%
-0.03
After Hours:
5.57
Inventiva Adr stock is traded at $5.57, with a volume of 69,149.
It is down -0.54% in the last 24 hours and up +71.38% over the past month.
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.
See More
Previous Close:
$5.60
Open:
$5.41
24h Volume:
69,149
Relative Volume:
1.84
Market Cap:
$775.07M
Revenue:
$9.96M
Net Income/Loss:
$-199.33M
P/E Ratio:
-1.6714
EPS:
-3.3326
Net Cash Flow:
$-93.38M
1W Performance:
-10.02%
1M Performance:
+71.38%
6M Performance:
+101.81%
1Y Performance:
+148.66%
1-Day Range:
$5.27
$5.7499
1-Week Range:
$5.21
$6.10
52-Week Range:
$1.53
$6.4999
Inventiva Adr Stock (IVA) Company Profile
Compare IVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
5.57 | 778.73M | 9.96M | -199.33M | -93.38M | -3.3326 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-03-25 | Resumed | H.C. Wainwright | Buy |
| Aug-27-25 | Initiated | Piper Sandler | Overweight |
| Feb-21-25 | Initiated | TD Cowen | Buy |
| Nov-12-24 | Initiated | UBS | Neutral |
| Oct-27-23 | Initiated | Canaccord Genuity | Buy |
| May-31-23 | Initiated | ROTH MKM | Buy |
| May-19-23 | Upgrade | Societe Generale | Sell → Buy |
| Mar-17-23 | Initiated | Stifel | Buy |
| Nov-15-22 | Downgrade | Societe Generale | Buy → Sell |
| Mar-08-21 | Downgrade | Societe Generale | Buy → Sell |
| Aug-05-20 | Initiated | ROTH Capital | Buy |
| Aug-04-20 | Initiated | Guggenheim | Buy |
| Aug-04-20 | Initiated | Stifel | Buy |
View All
Inventiva Adr Stock (IVA) Latest News
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Increases By 188.0% - Defense World
HC Wainwright Forecasts Inventiva FY2025 Earnings - Defense World
Inventiva annonce sa participation à plusieurs conférences investisseurs en septembre - GlobeNewswire Inc.
Inventiva (NASDAQ:IVA) Shares Gap Up on Analyst Upgrade - Defense World
Inventiva (NASDAQ:IVA) Price Target Raised to $13.00 at Guggenheim - Defense World
Why Did Inventiva Stock Plunge 10.82%? - AInvest
Inventiva (NASDAQ:IVA) Shares Gap Down – Here’s What Happened - Defense World
Inventiva (NASDAQ:IVA) Earns Overweight Rating from Analysts at Piper Sandler - Defense World
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $10.40 Average Price Target from Brokerages - Defense World
How Much Upside is Left in Inventiva (IVA)? Wall Street Analysts Think 100.79% - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
Inventiva (NASDAQ:IVA) Trading 4.3% Higher – What’s Next? - Defense World
Wealth Enhancement Advisory Services LLC Acquires New Shares in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) - Defense World
Rokmaster Resources (CVE:RKR) Stock Price Up 71.4% – Still a Buy? - Defense World
Portofino Resources (CVE:POR) Trading Up 100% – Should You Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Stock Price Up 25% – Time to Buy? - Defense World
Northern Dynasty Minerals (TSE:NDM) Shares Up 25% – Here’s Why - Defense World
Portofino Resources (CVE:POR) Stock Price Up 100% – Time to Buy? - Defense World
Honey Badger Silver (CVE:TUF) Trading Down 12% – Here’s What Happened - Defense World
Voyageur Pharmaceuticals (CVE:VM) Trading Down 11.5% – Here’s Why - Defense World
Inventiva (NASDAQ:IVA) Trading 2.7% Higher – Here’s Why - Defense World
Inventiva (IVA) Upgraded to Buy: What Does It Mean for the Stock? - MSN
Inventiva sets share repurchase program terms post-meeting - Investing.com
Is Elicio Therapeutics, Inc. (ELTX) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Inventiva achieves milestone with Phase 3 study enrollment, says H.C. Wainwright - TipRanks
Stifel maintains Buy on Inventiva shares with $17 target - Investing.com
Inventiva SA ADR Reports 2024 Financial Results and Strategic Updates - TipRanks
Inventiva earnings missed by $0.03, revenue topped estimates - Investing.com
Top 10 Best Indian Companies In Smart Grids Solutions 2025 - inventiva.co.in
Why Are Criminals Still in Power? 151 Lawmakers with Charges of Crimes Against Women Continue to Hold Office! Is This the End of Integrity in Indian Politics? - inventiva.co.in
Down -27.95% in 4 Weeks, Here's Why You Should You Buy the Dip in Inventiva (IVA) - Nasdaq
NOTA, No Votes and Unopposed Nominations: The Grey Areas of the Indian Election Process Explained - inventiva.co.in
Supreme Court To Hear Plea Against Electoral Bonds From October 31 - Inventiva
PM Modi Says Reservation Act To Give A New Direction To Women-led Development - inventiva.co.in
Top 10 Best Handicraft Companies In USA 2023 - inventiva.co.in
Top 20 Best Hardware & Networking Company In India 2023 - inventiva.co.in
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study - Yahoo Finance
IVA Stock Price and Chart — NASDAQ:IVA - TradingView
IVA News Today | Why did Inventiva stock go up today? - MarketBeat
Inventiva (IVA) Stock Price, News & Analysis - MarketBeat
Inventiva Adr Stock (IVA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.40%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):